President Donald Trump, with FBI Director Kash Patel listening, speaks in Washington on Oct. 15, 2025. Kevin Dietsch/Getty Images
The Trump administration is in negotiations to obtain popular weight-loss drug Ozempic at a dramatically reduced price in the United States, according to President Donald Trump.
The drug, made by Danish manufacturer Novo Nordisk, will be sold at most-favored nation pricing, meaning the lowest price available in developed countries.
We had a problem loading this article. Please enable javascript or use a different browser. If the issue persists, please visit our help center.